T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Trimble
TRMB
$13.4B
| $365M | 0.08% |
14,501,107
+996,701
| +7% | +$25.6M |
|
302
Liberty Global Class A
LBTYA
$3.58B
| $365M | 0.08% |
8,597,151
+577,863
| +7% | +$24.1M |
|
303
Newmont
NEM
$120B
| $362M | 0.07% |
16,689,086
-584,347
| -3% | -$13.7M |
|
304
Ball Corp
BALL
$16.4B
| $362M | 0.07% |
10,255,822
-191,240
| -2% | -$6.62M |
|
305
SL Green Realty
SLG
$4.08B
| $362M | 0.07% |
2,912,910
+310,683
| +12% | +$38.4M |
|
|
TFCFA
306
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $360M | 0.07% |
10,628,611
-7,585,825
| -42% | -$263M |
|
|
THS
307
DELISTED
Treehouse Foods
THS
| $359M | 0.07% |
4,220,013
-151,030
| -3% | -$13M |
|
308
Accenture
ACN
$109B
| $357M | 0.07% |
3,815,092
-187,383
| -5% | -$16.7M |
|
309
Ford
F
$55.4B
| $357M | 0.07% |
22,145,667
+284,440
| +1% | +$4.49M |
|
310
Canadian Pacific Kansas City
CP
$82.6B
| $354M | 0.07% |
9,697,265
-1,338,305
| -12% | -$49.4M |
|
|
SHPG
311
DELISTED
Shire pic
SHPG
| $354M | 0.07% |
1,478,092
+1,431,215
| +3,053% | +$329M |
|
|
DGI
312
DELISTED
DigitalGlobe Inc.
DGI
| $353M | 0.07% |
10,365,893
-594,090
| -5% | -$18.5M |
|
313
LPL Financial
LPLA
$29.5B
| $353M | 0.07% |
8,050,762
-464,455
| -5% | -$20.5M |
|
314
Stryker
SYK
$131B
| $352M | 0.07% |
3,812,086
-192,476
| -5% | -$17.9M |
|
315
RH
RH
$3.4B
| $349M | 0.07% |
3,513,749
-11,580
| -0.3% | -$1.05M |
|
316
Cencora
COR
$59.2B
| $348M | 0.07% |
3,059,631
+21,183
| +0.7% | +$2.13M |
|
317
Rayonier
RYN
$6.54B
| $345M | 0.07% |
14,114,091
+346,428
| +3% | +$8.81M |
|
318
Diamondback Energy
FANG
$55.9B
| $344M | 0.07% |
4,480,759
+62,551
| +1% | +$4.34M |
|
319
First American
FAF
$7.56B
| $344M | 0.07% |
9,639,411
-1,082,180
| -10% | -$37.6M |
|
320
Ingredion
INGR
$6.63B
| $343M | 0.07% |
4,409,538
+113,520
| +3% | +$9.29M |
|
321
Xcel Energy
XEL
$49.3B
| $343M | 0.07% |
9,847,382
-3,940,768
| -29% | -$141M |
|
322
McCormick & Company Non-Voting
MKC
$14.6B
| $342M | 0.07% |
8,867,132
+58,350
| +0.7% | +$2.17M |
|
|
WFM
323
DELISTED
Whole Foods Market Inc
WFM
| $342M | 0.07% |
6,563,001
-270,706
| -4% | -$14.5M |
|
324
Viavi Solutions
VIAV
$10.6B
| $341M | 0.07% |
45,728,175
+178,277
| +0.4% | +$1.35M |
|
|
TW
325
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $341M | 0.07% |
2,579,499
+984,447
| +62% | +$123M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.